BTK and non-small cell lung carcinoma: In particular, the 80 kDa isoform has been reported in breast and prostate carcinomas [8,11], whereas BTK-p65 has been shown to be abundantly expressed in colon [13,14] and ovarian carcinomas [10], glioblastomas [18] and NSCLC [19].